SANA - Sana Biotechnology - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

573M

Cash

325.9M

Avg Qtr Burn

-69.73M

Short % of Float

21.06%

Insider Ownership

10.43%

Institutional Own.

92.79%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
SC291 (CD19) Details B-cell malignancies	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.